Abstract
Background: There are no international consensus guidelines on IPNB. Method: An international‐multidisciplinary panel performed a critical appraisal of the literature and used a two‐round Delphi process to evaluate 24 critical clinical questions, incorporating community feedback from a dedicated 2025 A‐PHPBA meeting session in Bangkok. Results: Salient aspects of the recommendations: (1) IPNB is analogous to intracholecystic papillary neoplasm (ICPNs)/intraductal papillary mucinous neoplasm (IPMNs), ranging from innocuous cystic lesions to papillary in situ carcinomas to invasive carcinomas. (2) Possible etiologic factors like stones, parasites, PSC, and PBM/choledochal cysts should be assessed in every case. (3) All nonmetastatic IPNBs are candidates for oncologic resection, preferably along with lymph node dissection. (4) Pre‐ and intraoperative assessment for multifocality is important. (5) Liver transplant is a consideration in selected cases. (6) Individualized IPNB‐focused synoptic pathology reports were devised for use. (7) For invasive IPNBs, adjuvant treatment should follow standard cholangiocarcinoma protocols. (8) Follow‐up should mirror main‐duct IPMN protocols, adjusted for invasion and margin status. (9) For isolated IPNB recurrence, resection or transplant is advisable; if infeasible or metastatic, consider ablative and systemic therapies. (10) These recommendations are also applicable to IOPN/ITPN but with subtle differences. Conclusion: These recommendations should aid in cross‐national standardized classification, diagnosis, reporting, and management of IPNBs, and serve as a launching pad for further studies.

This publication has 91 references indexed in Scilit: